$NOW Recent Headlines Facebook, Twitter

New Post Public Reply Private Reply Replies (0) Message Board

Feb 4, 2014 at 3:59 PM

$NOW Recent Headlines

Facebook, Twitter highlight gainers; ADT unravels
3:56 p.m. Jan. 30, 2014
- Sue Chang

Charting the early-2014 ‘pullback’
12:33 p.m. Jan. 9, 2014
- Michael Ashbaugh

Nuance, Workday, J.C. Penney in focus Monday
8:00 a.m. Nov. 24, 2013
- MarketWatch

Apple, Amazon get attention ahead of earnings
4:02 p.m. Oct. 25, 2012
- Rex Crum

AMD losses lead weak day for tech stocks
3:54 p.m. Oct. 12, 2012
- Rex Crum

Workday soars as IPO rides cloud trend
3:38 p.m. Oct. 12, 2012
- Benjamin Pimentel

Stocks: More decay is on the way
7:17 a.m. Oct. 11, 2012
- The Trading Deck

Leading stocks nicked amid flight to safety
5:56 a.m. Sept. 27, 2012
- The Trading Deck

Stocks: Calm before the storm?
11:17 a.m. Sept. 4, 2012
- The Trading Deck

Cisco gains lead upbeat day for tech stocks
3:38 p.m. Aug. 9, 2012
- Rex Crum

ServiceNow reports $8.7 million loss
3:11 p.m. Aug. 1, 2012
- Rex Crum

ServiceNow Q2 loss 32c vs 2c EPS year ago
3:06 p.m. Aug. 1, 2012
- Wallace Witkowski

Stocks idle before data deluge
11:01 p.m. July 30, 2012
- The Trading Deck

Avast, E2open next tech IPOs on deck
1:15 p.m. July 23, 2012
- Rex Crum

Stocks to watch Thursday: Supervalu, Callaway
5:46 a.m. July 12, 2012
- MarketWatch

Palo Alto, Kayak to test IPO market recovery
4:09 p.m. July 9, 2012
- Rex Crum

Facebook gains slightly, but most techs slip
3:52 p.m. July 9, 2012
- Rex Crum

Stocks to watch Monday: Acuity, ServiceNow
6:02 a.m. June 30, 2012
- Taylor Thomas

ServiceNow revives IPO market…in time for vacation

4:55 p.m. June 29, 2012
- blogs.marketwatch.com

Friday’s biggest gaining and declining stocks
3:26 p.m. June 29, 2012
- MarketWatch

AtTask Garners $38 million Funding Round

7:33 a.m. Today7:33 a.m. Feb. 4, 2014
- TheStreet.com

CYREN: An Israeli Cyber-Security Company With Growing Revenue, A New Cloud Product

7:31 a.m. Today7:31 a.m. Feb. 4, 2014
- Seeking Alpha

Cramer's Mad Money - Dow Report Card (1/30/14)

6:13 a.m. Jan. 31, 2014
- Seeking Alpha

Jim Cramer's 'Mad Money' Recap: Social, Mobile, Cloud Are Buys

8:19 p.m. Jan. 30, 2014
- TheStreet.com

Salesforce, Workday, others follow ServiceNow higher

1:16 p.m. Jan. 30, 2014
- Seeking Alpha

ServiceNow Gets Price Hikes On 'Outstanding Results'

10:04 a.m. Jan. 30, 2014
- Investors Business Daily

UPDATE: ServiceNow Upgraded by Baird After Exceptional 4Q, Trading Up 19 Percent

9:57 a.m. Jan. 30, 2014
- benzinga.com

New Lifetime High For ServiceNow (NOW)

9:45 a.m. Jan. 30, 2014
- TheStreet.com

Robert W. Baird Upgrades ServiceNow to Outperform

9:30 a.m. Jan. 30, 2014
- TheStreet.com

The Day Ahead: Facebook Soars on Mobile

8:42 a.m. Jan. 30, 2014
- RealMoney.com

ServiceNow Management Discusses Q4 2013 Results - Earnings Call Transcript

9:20 p.m. Jan. 29, 2014
- Seeking Alpha

ServiceNow Beats Q4 Revenue Estimate And Q1 Views

5:31 p.m. Jan. 29, 2014
- Investors Business Daily

ServiceNow issues strong guidance, shares +4.2% AH

5:05 p.m. Jan. 29, 2014
- Seeking Alpha

Trade-Ideas: ServiceNow (NOW) Is Today's Post-Market Leader Stock

4:16 p.m. Jan. 29, 2014
- TheStreet.com

ServiceNow Q4 Expected To Show Market Share Gains

10:42 a.m. Jan. 28, 2014
- Investors Business Daily

ServiceNow Inc (NOW): Today's Featured Technology Winner

5:00 p.m. Jan. 23, 2014
- TheStreet.com

ServiceNow's Market Cap Has Gotten Ahead Of Its Future Growth Story

8:30 a.m. Jan. 23, 2014
- Seeking Alpha

Cloud Picks for Solid Fourth Quarters

1:06 p.m. Jan. 22, 2014
- Barrons.com

Interesting NOW Put And Call Options For March 22nd

11:57 a.m. Jan. 22, 2014
- TheStreet.com

IBM Earnings – Don’t Expect Big Blue to Get Out of Its Slump

7:23 a.m. Jan. 21, 2014
- InvestorPlace.com

ServiceNow Reports Financial Results for Fourth Quarter and Fiscal
Year 2013
4:02 p.m. Jan. 29, 2014
- BusinessWire - BZX

Cloud Sherpas Doubles ServiceNow Business in 2013
2:01 p.m. Jan. 8, 2014
- Marketwire

Tickets.com Transforms IT Service Delivery with ServiceNow
8:00 a.m. Jan. 7, 2014
- BusinessWire

ServiceNow to Announce Fourth Quarter and Fiscal Year 2013 Financial Results on Wednesday, January 29, 2014
8:00 a.m. Jan. 2, 2014
- BusinessWire

Business Partnerships, Portfolio Expansions, Successful Deployments, New Applications and Service Contracts - Research Report on IBM, Rackspace, NCR, ServiceNow, and Unisys
8:00 a.m. Dec. 20, 2013
- PR Newswire

ServiceNow Adds to IT Service Automation Suite
8:00 a.m. Dec. 10, 2013
- BusinessWire

ServiceNow Adds to IT Operations Management Portfolio
8:00 a.m. Dec. 10, 2013
- BusinessWire

ServiceNow Wins Techworld Award for Best SaaS Product of 2013
8:00 a.m. Dec. 5, 2013
- BusinessWire

Common Stock Offering, New Facilities, Startup Programs, and Search Engine Partnerships - Research Report on Nielsen, Groupon, ServiceNow, Rackspace, and TripAdvisor
8:00 a.m. Nov. 27, 2013
- PR Newswire

Hellman & Friedman to Acquire Applied Systems
9:01 a.m. Nov. 26, 2013
- BusinessWire

ServiceNow to Participate in Upcoming Investor Conference
8:00 a.m. Nov. 22, 2013
- BusinessWire

Early Morning Insight: Yingli Green Energy Holding Co. Ltd, International Game Technology, Fairchild Semiconductor Intl. Inc., and ServiceNow Inc.
9:12 a.m. Nov. 21, 2013
- PR Newswire

Charles Giancarlo Joins ServiceNow Board of Directors
4:02 p.m. Nov. 19, 2013
- BusinessWire

Forest City Enterprises Deploys ServiceNow to Automate Business Services
8:00 a.m. Nov. 19, 2013
- BusinessWire

Red Hat Drives IT Modernization and Scale with ServiceNow
8:00 a.m. Nov. 18, 2013
- BusinessWire

ServiceNow Implements HR Case Management
8:00 a.m. Nov. 12, 2013
- BusinessWire

ServiceNow Mobilizes The Enterprise
8:00 a.m. Nov. 12, 2013
- BusinessWire

Proposed Offerings, Financial Results, Scheduled Conferences, Dividends, and New Contracts - Research Report on ServiceNow, Acxiom, 21Vianet, Unisys, and iGATE
8:00 a.m. Nov. 11, 2013
- PR Newswire

ServiceNow Prices $500 Million of 0% Convertible Senior Notes Due 2018
2:57 a.m. Nov. 7, 2013
- BusinessWire

ServiceNow to Offer $500 Million Convertible Senior Notes due 2018
4:15 p.m. Nov. 5, 2013
- BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...